Anaemia is defined by a low red blood cell count. It is the world’s second leading cause of disability, with 1.6 billion sufferers globally. Although it has multiple causes, once they are identified anaemia is often curable.
Based on proprietary technology developed at Imperial College, Toby’s start-up company Eva Diagnostics is developing two affordable handheld anaemia diagnostic devices.
The first one is AnemiPoint, which can be used to identify the presence of anaemia in patients. The other device AnemiStat will identify different types of anaemia.
This is a market-first development in point-of-care anaemia diagnosis that enables clinicians to provide tailored treatments for patients. Eva Diagnostics plans to focus on the global market and the $1 billion or more spend on anaemia-related costs.